15 Results

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Zakowski
    Zakowski
  4. Ginsberg
    Ginsberg
  5. Ladanyi
    Ladanyi
  6. Azzoli
    Azzoli
  7. Johnson
    Johnson
  8. Sima
    Sima
  9. Yu
    Yu
  10. Zheng
    Zheng

Groups

  1. Department of Medicine (10)
  2. Solid Tumor Oncology Division (10)
  3. Thoracic Oncology (10)
  4. Department of Pathology and Laboratory Medicine (4)
  5. Biostatistics Service (3)
  6. Body Imaging Service (3)
  7. Epidemiology and Biostatistics (3)
  8. GSK Faculty (3)
  9. Human Oncology and Pathogenesis Program (3)
  10. Radiology, Department of (3)
  1. "egfr mutation"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (4)
  3. Review (1)
Groups
  1. Department of Medicine (10)
  2. Solid Tumor Oncology Division (10)
  3. Thoracic Oncology (10)
  4. Department of Pathology and Laboratory Medicine (4)
  5. Biostatistics Service (3)
  6. Body Imaging Service (3)

More Groups

People
  1. Maureen Zakowski (6)
  2. Gregory Riely (4)
  3. Mark Kris (4)
  4. Marc Ladanyi (3)
  5. Michelle Ginsberg (3)
  6. Camelia Sima (2)

More People

Years
  1. 2025 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2018 (2)
  5. 2015 (2)
  6. 2012 (1)

More Years

Publications
  1. Journal of Thoracic Oncology (8)
  2. Lung Cancer (2)
  3. Annals of Oncology (1)
  4. Clinical Advances in Hematology & Oncology (1)
  5. Clinical Lung Cancer (1)
  6. Journal of the National Comprehensive Cancer Network (1)

More Publications

Publishers
  1. Elsevier Inc. (9)
  2. Elsevier Ireland Ltd. (2)
  3. Harborside Press (1)
  4. Millennium Medical Publishing, Inc (1)
  5. Oxford University Press (1)
  6. Thieme Publishing (1)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Management of oligoprogressive and oligopersistent disease in advanced NSCLC
    Review

    Ravella, R.; Feliciano, E. J. G.; Dee, E. C.; Gomez, D. R.; Iyengar, P.
    Clinical Advances in Hematology & Oncology (2025)

    Fulltext@MSK | Save
  • TATTON: A multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
    Journal Article

    Oxnard, G. R.; Yang, J. C. H.; Yu, H.; Kim, S. W.; Saka, H.; Horn, L.; Goto, K.; Ohe, Y.; Mann, H.; Thress, K. S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Real-world outcomes of advanced NSCLC patients with common and uncommon/complex EGFR mutation profiles
    Meeting Abstract

    Riely, G.; Lovly, C.; Messina, C.; Bienert, S.; Alexander, K.; Pao, W.; Magee, K.; Baxi, S.; Doebele, R.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Phase 1 study of the anti-HER3 antibody drug conjugate U3-1402 in metastatic or unresectable EGFR-mutant NSCLC
    Meeting Abstract

    Jänne, P.; Yu, H.; Johnson, M.; Steuer, C.; Vigliotti, M.; Shipitofsky, N.; Guevara, F. M.; Chen, S.; Yu, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Phase 3 study of pemetrexed-platinum with or without pembrolizumab for TKI-resistant/EGFR-mutated advanced NSCLC: KEYNOTE-789
    Meeting Abstract

    Riely, G.; Hui, R.; Carbone, D.; Park, K.; Carrigan, M.; Xu, X.; Dang, T.; Yang, J. C. H.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Prognostic impact of EGFR and KRAS mutations in patients with lung adenocarcinoma treated with definitive radiation therapy
    Meeting Abstract

    Oro, F.; Sonnick, M.; Wang, H.; Zakowski, M.; Wu, A. J.; Chaft, J. E.; Paik, P.; Tsang, M.; Hsu, M.; Rosenzweig, K.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?
    Journal Article

    Plodkowski, A. J.; Drilon, A.; Halpenny, D. F.; O'Driscoll, D.; Blair, D.; Litvak, A. M.; Zheng, J.; Moskowitz, C. S.; Ginsberg, M. S.
    Lung Cancer (2015)

    Fulltext@MSK | Save
  • Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma
    Journal Article

    Hasanovic, A.; Ang, D.; Moreira, A. L.; Zakowski, M. F.
    Lung Cancer (2012)

    Fulltext@MSK | Save
  • Pathological diagnosis and classification of lung cancer in small biopsies and cytology: Strategic management of tissue for molecular testing
    Journal Article

    Travis, W. D.; Rekhtman, N.
    Seminars in Respiratory and Critical Care Medicine (2011)

    Fulltext@MSK | Save
  • Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib
    Journal Article

    Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Sima, C. S.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save